TN-401
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TN-401, covering 2025-02-06 to 2025-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC [Phase 1]